Astria Therapeutics
ATXS
ATXS
103 hedge funds and large institutions have $622M invested in Astria Therapeutics in 2024 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 33 increasing their positions, 38 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
1.07% less ownership
Funds ownership: 101.22% → 100.15% (-1.1%)
13% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 38
37% less call options, than puts
Call options by funds: $482K | Put options by funds: $769K
Holders
103
Holding in Top 10
1
Calls
$482K
Puts
$769K
Top Buyers
| 1 | +$19.5M | |
| 2 | +$8.26M | |
| 3 | +$7.09M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$3.42M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$3.31M |
Top Sellers
| 1 | -$8.55M | |
| 2 | -$6.87M | |
| 3 | -$5.45M | |
| 4 |
AAA
Affinity Asset Advisors
New York
|
-$2.76M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$2.56M |